Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Jul-10 3:26 PM View:  | Kiernan Peter D. III Director | Javelin Pharmaceuticals, Inc. (JAV) | 02-Jul-10 | Disposition | 2,411,850 | $2.20 | $5,306,070.00 | (100%) 2.41M to 0 | 0% |
| 02-Jul-10 3:20 PM View: | Flanzraich Neil Director | Javelin Pharmaceuticals, Inc. (JAV) | 02-Jul-10 | Disposition | 1,000,000 | $2.20 | $2,200,000.00 | (100%) 1000.0K to 0 | 0% |
| 02-Jul-10 3:14 PM View: | Tulipano Stephen J CFO and Secretary | Javelin Pharmaceuticals, Inc. (JAV) | 02-Jul-10 | Disposition | 12,500 | $2.20 | $27,500.00 | (100%) 12.5K to 0 | 0% |
| 02-Jul-10 3:23 PM View: | Carr Daniel B President and CMO Director | Javelin Pharmaceuticals, Inc. (JAV) | 02-Jul-10 | Disposition | 59,524 | $2.20 | $130,953.00 | (100%) 59.52K to 0 | 0% |
| 02-Jul-10 3:19 PM View: | Driscoll Martin J Chief Executive Officer Director | Javelin Pharmaceuticals, Inc. (JAV) | 02-Jul-10 | Disposition | 239,053 | $2.20 | $525,917.00 | (100%) 239.05K to 0 | 0% |
| 02-Jul-10 3:17 PM View: | Watson Douglas G Director | Javelin Pharmaceuticals, Inc. (JAV) | 30-Jun-10 | Disposition (change in control) | 20,000 | $2.20 | $44,000.00 | (100%) 20.0K to 0 | 0% |
| 02-Jul-10 3:14 PM View: | Tulipano Stephen J CFO and Secretary | Javelin Pharmaceuticals, Inc. (JAV) | 30-Jun-10 | Disposition (change in control) | 10,115 | $2.20 | $22,253.00 | (45%) 22.61K to 12.5K | 0% |
| 02-Jul-10 3:17 PM View: | Mermelstein Fred H Director | Javelin Pharmaceuticals, Inc. (JAV) | 30-Jun-10 | Disposition (change in control) | 577,316 | $2.20 | $1,270,100.00 | (100%) 577.32K to 0 | 0% |
| 02-Jul-10 3:23 PM View: | Carr Daniel B President and CMO Director | Javelin Pharmaceuticals, Inc. (JAV) | 30-Jun-10 | Disposition (change in control) | 80,494 | $2.20 | $177,087.00 | (57%) 140.02K to 59.52K | 0% |
| 05-May-10 6:54 PM View: | Carr Daniel B President and CMO Director | Javelin Pharmaceuticals, Inc. (JAV) | 03-May-10 | Market Sale | 18,450 | $2.18 | $40,222.80 | (12%) 155.97K to 137.52K | (< 1%) |
| 05-May-10 7:01 PM View: | Tulipano Stephen J CFO and Secretary | Javelin Pharmaceuticals, Inc. (JAV) | 03-May-10 | Market Sale | 2,385 | $2.18 | $5,199.54 | (10%) 25.0K to 22.61K | (< 1%) |
| 29-Mar-10 2:38 PM View: | Carr Daniel B President and CMO Director | Javelin Pharmaceuticals, Inc. (JAV) | 26-Mar-10 | Market Option Sale | 700 | $1.35 | $945.00 | (< 1%) 156.67K to 155.97K | (63%) |
| 29-Mar-10 2:38 PM View: | Carr Daniel B President and CMO Director | Javelin Pharmaceuticals, Inc. (JAV) | 26-Mar-10 | Option Exercise | 767 | $1.07 | $820.69 | < 1% 155.9K to 156.67K | |
| 29-Mar-10 2:38 PM View: | Carr Daniel B President and CMO Director | Javelin Pharmaceuticals, Inc. (JAV) | 25-Mar-10 | Option Exercise | 5,307 | $1.07 | $5,678.49 | 3% 155.29K to 160.6K | |
| 29-Mar-10 2:38 PM View: | Carr Daniel B President and CMO Director | Javelin Pharmaceuticals, Inc. (JAV) | 25-Mar-10 | Market Option Sale | 4,700 | $1.35 | $6,345.00 | (3%) 160.6K to 155.9K | (63%) |
| 23-Mar-10 4:35 PM View: | Driscoll Martin J Chief Executive Officer Director | Javelin Pharmaceuticals, Inc. (JAV) | 19-Mar-10 | Market Purchase | 22,181 | $1.30 | $28,868.60 | 10% 214.37K to 236.55K | 69% |
| 03-Mar-10 4:22 PM View: | Flanzraich Neil Director | Javelin Pharmaceuticals, Inc. (JAV) | 03-Mar-10 | Market Purchase | 84,580 | $1.41 | $119,258.00 | 9% 915.42K to 1000.0K | 56% |
| 19-Feb-10 6:51 PM View: | Flanzraich Neil Director | Javelin Pharmaceuticals, Inc. (JAV) | 19-Feb-10 | Market Purchase | 100,000 | $1.42 | $142,000.00 | 12% 815.42K to 915.42K | 55% |
| 19-Feb-10 6:51 PM View: | Flanzraich Neil Director | Javelin Pharmaceuticals, Inc. (JAV) | 18-Feb-10 | Market Purchase | 11,000 | $1.42 | $15,620.00 | 1% 804.42K to 815.42K | 55% |
| 16-Feb-10 5:32 PM View: | Flanzraich Neil Director | Javelin Pharmaceuticals, Inc. (JAV) | 16-Feb-10 | Market Purchase | 50,000 | $1.36 | $67,830.00 | 7% 754.42K to 804.42K | 62% |
| 16-Feb-10 5:32 PM View: | Flanzraich Neil Director | Javelin Pharmaceuticals, Inc. (JAV) | 12-Feb-10 | Option Exercise | 24,000 | $1.26 | $30,240.00 | 4% 614.94K to 638.94K | 75% |
| 16-Feb-10 5:32 PM View: | Flanzraich Neil Director | Javelin Pharmaceuticals, Inc. (JAV) | 12-Feb-10 | Market Purchase | 115,483 | $1.25 | $144,215.00 | 18% 638.94K to 754.42K | 76% |
| 17-Feb-10 6:23 PM View: | Driscoll Martin J Chief Executive Officer Director | Javelin Pharmaceuticals, Inc. (JAV) | 12-Feb-10 | Market Purchase | 6,331 | $1.27 | $8,040.37 | 3% 188.15K to 194.48K | 73% |
| 22-Dec-09 5:37 PM View: | Tulipano Stephen J CFO and Secretary | Javelin Pharmaceuticals, Inc. (JAV) | 18-Dec-09 | Grant | 10,000 | -- | -- | 67% 15.0K to 25.0K | |
| 05-May-09 5:23 PM View: | Carr Daniel B President and CMO Director | Javelin Pharmaceuticals, Inc. (JAV) | 01-May-09 | Grant | 104,167 | -- | -- | 333% 31.25K to 135.41K | |
| 05-May-09 5:22 PM View: | Driscoll Martin J Chief Executive Officer Director | Javelin Pharmaceuticals, Inc. (JAV) | 01-May-09 | Grant | 104,167 | -- | -- | 124% 83.98K to 188.15K | |
| 05-May-09 5:22 PM View: | Tulipano Stephen J CFO and Secretary | Javelin Pharmaceuticals, Inc. (JAV) | 01-May-09 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 18-Nov-08 12:46 PM View: | Watson Douglas G Director | Javelin Pharmaceuticals, Inc. (JAV) | 17-Nov-08 | Market Purchase | 7,000 | $0.93 | $6,519.00 | 54% 13.0K to 20.0K | 139% |
| 01-Jul-08 10:23 AM View: | Watson Douglas G Director | Javelin Pharmaceuticals, Inc. (JAV) | 30-Jun-08 | Market Purchase | 3,000 | $2.39 | $7,170.00 | 30% 10.0K to 13.0K | (27%) |
| 27-Jun-08 2:00 PM View: | Watson Douglas G Director | Javelin Pharmaceuticals, Inc. (JAV) | 26-Jun-08 | Market Purchase | 5,000 | $2.34 | $11,700.00 | 100% 5.0K to 10.0K | (25%) |
| 27-Jun-08 1:59 PM View: | Mermelstein Fred H Executive Director Director | Javelin Pharmaceuticals, Inc. (JAV) | 26-Jun-08 | Market Purchase | 20,000 | $2.30 | $46,000.00 | 4% 552.32K to 572.32K | (24%) |
| 26-Jun-08 7:23 PM View: | Driscoll Martin J Chief Executive Officer Director | Javelin Pharmaceuticals, Inc. (JAV) | 26-Jun-08 | Market Purchase | 30,000 | $2.32 | $69,600.00 | 58% 51.49K to 81.49K | (25%) |
| 15-May-08 10:45 AM View: | Carr Daniel B Chief Medical Officer Director | Javelin Pharmaceuticals, Inc. (JAV) | 13-May-08 | Private Purchase | 20,746 | $2.41 | $49,997.90 | 259% 8.0K to 28.75K | 37% |
| 15-May-08 10:44 AM View: | Driscoll Martin J Chief Executive Officer Director | Javelin Pharmaceuticals, Inc. (JAV) | 13-May-08 | Private Purchase | 41,493 | $2.41 | $99,998.10 | 100% 0 to 41.49K | 37% |
| 15-May-08 10:43 AM View: | Flanzraich Neil Director | Javelin Pharmaceuticals, Inc. (JAV) | 13-May-08 | Private Purchase | 414,937 | $2.41 | $999,998.00 | 207% 200.0K to 614.94K | 37% |
| 15-May-08 11:58 AM View: | Wexford Capital LLC | Javelin Pharmaceuticals, Inc. (JAV) | 13-May-08 | Private Purchase | 892,116 | $2.41 | $2,150,000.00 | 19% 4.79M to 5.68M | 37% |
| 27-Feb-08 9:38 PM View: | Kiernan Peter D. III Director | Javelin Pharmaceuticals, Inc. (JAV) | 20-Feb-08 | Market Purchase | 24,400 | $3.17 | $77,259.60 | < 1% 4.78M to 4.8M | (45%) |
| 27-Feb-08 9:37 PM View: | Kiernan Peter D. III Director | Javelin Pharmaceuticals, Inc. (JAV) | 20-Feb-08 | Market Purchase | 25,600 | $3.07 | $78,527.00 | < 1% 4.62M to 4.65M | (43%) |
| 27-Feb-08 9:37 PM View: | Kiernan Peter D. III Director | Javelin Pharmaceuticals, Inc. (JAV) | 19-Feb-08 | Market Purchase | 100,000 | $3.07 | $306,788.00 | 2% 4.52M to 4.62M | (43%) |
| 09-Nov-07 6:57 PM View: | Driscoll Martin J Director | Javelin Pharmaceuticals, Inc. (JAV) | 08-Nov-07 | Market Purchase | 10,000 | $4.40 | $43,972.00 | (78%) 12.8K to 2.8K | 60% |
| 08-Jun-07 5:02 PM View: | Nebgen Georg Director | Javelin Pharmaceuticals, Inc. (JAV) | 01-Jun-07 | Exercise (in-the money or at-the-money) | 155,555 | $2.25 | $349,999.00 | 5% 3.02M to 3.18M | |
| 28-Dec-06 5:02 PM View: | Rosenwald Lindsay A Md 10% Owner | Javelin Pharmaceuticals, Inc. (JAV) | 28-Dec-06 | Gift | 350,000 | -- | -- | (8%) 4.36M to 4.01M | |
| 20-Dec-06 4:18 PM View: | Matthews Mark VP - Commercial Affairs | Javelin Pharmaceuticals, Inc. (JAV) | 18-Dec-06 | Market Purchase | 3,500 | $4.45 | $15,575.00 | 23% 15.0K to 18.5K | (61%) |
| 08-Dec-06 2:36 PM View: | Flanzraich Neil Director | Javelin Pharmaceuticals, Inc. (JAV) | 06-Dec-06 | Market Purchase | 93,200 | $4.00 | $372,539.00 | 87% 106.8K to 200.0K | (56%) |
| 20-Dec-06 4:18 PM View: | Matthews Mark VP - Commercial Affairs | Javelin Pharmaceuticals, Inc. (JAV) | 05-Dec-06 | Market Purchase | 5,000 | $3.85 | $19,250.00 | 50% 10.0K to 15.0K | (55%) |
| 06-Dec-06 5:41 PM View: | Matthews Mark VP - Commercial Affairs | Javelin Pharmaceuticals, Inc. (JAV) | 04-Dec-06 | Market Purchase | 5,000 | $3.85 | $19,250.00 | 100% 5.0K to 10.0K | (55%) |
| 01-Dec-06 11:14 AM View: | Kash Peter M Director | Javelin Pharmaceuticals, Inc. (JAV) | 29-Nov-06 | Market Purchase | 5,000 | $3.65 | $18,243.40 | 1% 464.43K to 469.43K | (52%) |
| 29-Nov-06 9:29 AM View: | Matthews Mark VP - Commercial Affairs | Javelin Pharmaceuticals, Inc. (JAV) | 27-Nov-06 | Market Purchase | 5,000 | $3.42 | $17,100.00 | 100% 0 to 5.0K | (49%) |
| 27-Nov-06 3:34 PM View: | Flanzraich Neil Director | Javelin Pharmaceuticals, Inc. (JAV) | 24-Nov-06 | Market Purchase | 10,100 | $3.35 | $33,832.00 | 10% 96.7K to 106.8K | (48%) |
| 27-Nov-06 3:32 PM View: | Carr Daniel B CEO & CMO Director | Javelin Pharmaceuticals, Inc. (JAV) | 22-Nov-06 | Market Purchase | 4,000 | $3.45 | $13,800.00 | 100% 4.0K to 8.0K | (49%) |
